| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/28/2000 | WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
| 09/28/2000 | WO2000056709A1 Indolinone compounds as kinase inhibitors |
| 09/28/2000 | WO2000056704A1 Hydroxamic and carboxylic acid derivatives |
| 09/28/2000 | WO2000056702A1 Resorcinol derivatives |
| 09/28/2000 | WO2000056693A1 Method of industrial-scale purification of lactic acid |
| 09/28/2000 | WO2000056685A1 Methods for the preparation of biphenyl isoxazole sulfonamides |
| 09/28/2000 | WO2000056681A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 09/28/2000 | WO2000056464A1 Atomising nozzle |
| 09/28/2000 | WO2000056405A2 Human tumor necrosis factor receptor-like 2 |
| 09/28/2000 | WO2000056404A1 Formulations for treatment of pain comprising vitamin b12 and phenylanine |
| 09/28/2000 | WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 09/28/2000 | WO2000056374A1 Muscle tissue engineering |
| 09/28/2000 | WO2000056366A1 Gel-microemulsion formulations |
| 09/28/2000 | WO2000056364A1 Propofol formulation containing tris |
| 09/28/2000 | WO2000056345A2 Methods for limiting scar and adhesion formation |
| 09/28/2000 | WO2000056343A1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence |
| 09/28/2000 | WO2000056342A2 Use of stabilised oligonucleotides for preparing a medicine with antitumour activity |
| 09/28/2000 | WO2000056341A1 Chemical compounds and their uses |
| 09/28/2000 | WO2000056340A1 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 09/28/2000 | WO2000056338A1 Quinazoline formulations and therapeutic use thereof |
| 09/28/2000 | WO2000056337A1 Agents for relieving side effects |
| 09/28/2000 | WO2000056336A2 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin |
| 09/28/2000 | WO2000056335A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 09/28/2000 | WO2000056334A1 Use of imino sugars for anti-tumor therapy |
| 09/28/2000 | WO2000056333A1 Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance |
| 09/28/2000 | WO2000056332A1 Sultams: catalyst systems for asymmetric reduction of a c=n intermediate biological compositions and methods for making the sultams |
| 09/28/2000 | WO2000056331A1 Inhibitors of impdh enzyme |
| 09/28/2000 | WO2000056330A1 Carnitine supplemented diet to prevent or alleviate ascites in broiler type poultry |
| 09/28/2000 | WO2000056329A1 Preventives/remedies for arteriosclerosis |
| 09/28/2000 | WO2000056328A1 Increasing cerebral bioavailability of drugs |
| 09/28/2000 | WO2000056327A1 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 09/28/2000 | WO2000056326A1 Use of vitamin c or analogues for promoting transformation of inactive procollagen into active collagen |
| 09/28/2000 | WO2000056325A2 Ibuprofen solution |
| 09/28/2000 | WO2000056324A1 The use of certain affinity nmda antagonists as antidepressants |
| 09/28/2000 | WO2000056323A1 Treatment of certain cancers associated with weight gain |
| 09/28/2000 | WO2000056322A1 Treatment to lower platelet adhesiveness |
| 09/28/2000 | WO2000056321A1 Treatment of hyperactivity disorders |
| 09/28/2000 | WO2000056320A1 Treatment of menstrual function |
| 09/28/2000 | WO2000056319A1 Treatment of orthostatic hypotension |
| 09/28/2000 | WO2000056318A1 Treatment of neuropathic pain or fibromyalgia |
| 09/28/2000 | WO2000056317A1 Weight loss after pregnancy |
| 09/28/2000 | WO2000056316A1 Treatment of gallstones |
| 09/28/2000 | WO2000056315A1 Treatment of pain |
| 09/28/2000 | WO2000056314A1 Method of treating sleep apnoea |
| 09/28/2000 | WO2000056313A1 Method of controlling weight gain associated with therapeutic drugs |
| 09/28/2000 | WO2000056312A1 Treatment of pulmonary hypertension |
| 09/28/2000 | WO2000056311A1 Control of metabolism |
| 09/28/2000 | WO2000056310A1 Treatment of chronic fatigue syndrome |
| 09/28/2000 | WO2000056309A1 Method of treating sexual dysfunction |
| 09/28/2000 | WO2000056308A1 Prevention of cardiovascular disease |
| 09/28/2000 | WO2000056307A1 Treatment of hiatial hernia |
| 09/28/2000 | WO2000056306A1 Treatment of osteoarthritis |
| 09/28/2000 | WO2000056304A2 Anti-inflammatory uses of manzamines |
| 09/28/2000 | WO2000056303A2 Treatment of immune diseases |
| 09/28/2000 | WO2000056302A2 Vanadium (iv) complexes containing catacholate ligand and having spermicidal activity |
| 09/28/2000 | WO2000056301A2 Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders |
| 09/28/2000 | WO2000056300A2 Synthesis and structure of metallocene compounds and their interactions with lipid membranes |
| 09/28/2000 | WO2000056299A2 The use of amifostine for the protection against tumor metastasis formation |
| 09/28/2000 | WO2000056298A2 Treatment of lyme disease with polysulfated glycosaminoglycan formulations |
| 09/28/2000 | WO2000056297A2 Pharmaceutical compositions comprising dipeptidy peptidase iv inhibitors for the promotion of growth |
| 09/28/2000 | WO2000056296A2 Compositions for improving fertility |
| 09/28/2000 | WO2000056294A2 Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry |
| 09/28/2000 | WO2000056293A2 Medicaments containing doxazosin-mesylate of crystalline modification d |
| 09/28/2000 | WO2000056292A2 Use of 1,2,4-triazolo[1,5-a]pyrimidine derivatives for treating migraine |
| 09/28/2000 | WO2000056290A1 Transdermal therapy system and method for producing the same |
| 09/28/2000 | WO2000056289A1 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof |
| 09/28/2000 | WO2000056282A1 Particle based vaccine composition |
| 09/28/2000 | WO2000056281A1 Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained |
| 09/28/2000 | WO2000056279A1 Resorcinol composition |
| 09/28/2000 | WO2000056278A1 Use of vitamin c or the like for stimulating skin cell synthesis |
| 09/28/2000 | WO2000056275A1 Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration |
| 09/28/2000 | WO2000056167A1 A method of preventing parturient hypocalcemia in animals and compositions used therein |
| 09/28/2000 | WO2000056155A1 Method of promoting angiogenesis |
| 09/28/2000 | WO2000056153A1 Oral low dose butyrate compositions |
| 09/28/2000 | WO2000056151A1 Method of treating obsessive-compulsive disorder |
| 09/28/2000 | WO2000056150A1 Treatment of premenstrual syndrome |
| 09/28/2000 | WO2000056149A1 Method of treating anxiety disorders |
| 09/28/2000 | WO2000056148A1 Treatment of pharmacology of drug misuse and other addictive disorders |
| 09/28/2000 | WO2000056145A1 Organ arrest, protection and preservation |
| 09/28/2000 | WO2000044359A3 Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections |
| 09/28/2000 | WO2000043392A3 Use of imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones as medicaments |
| 09/28/2000 | WO2000042942A3 Buccal drug delivery system for use in male contraception |
| 09/28/2000 | WO2000041740A3 Particles for oral delivery of peptides and proteins |
| 09/28/2000 | WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 09/28/2000 | WO2000041481A3 Medicament forms having controlled release and containing active substances which easily dissolve in water |
| 09/28/2000 | WO2000040693A3 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 09/28/2000 | WO2000040205A3 Sustained release formulation with reduced moisture sensitivity |
| 09/28/2000 | WO2000035428A3 Tricyclic nitrogen heterocycles as pde iv inhibitors |
| 09/28/2000 | WO2000033839B1 Non-peptide antagonists of glp-1 receptor and methods of use |
| 09/28/2000 | WO2000033822A9 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof |
| 09/28/2000 | WO2000028332A9 Methods and compositions to lower plasma cholesterol levels |
| 09/28/2000 | WO2000027424B1 Upregulation of endogenous prostaglandins to lower intraocular pressure |
| 09/28/2000 | WO2000025767A3 Use of triphenylbutene derivatives for the treatment of neurological disorders |
| 09/28/2000 | WO2000025727A3 Use of flumethasone, fluocinolone acetonide fluoromethasone for manufacture of a medicament for the treatment of tumours |
| 09/28/2000 | WO2000024396A9 Treatment of disorders of the outer retina |
| 09/28/2000 | WO2000024389A3 Benzoquinoline derivatives useful as antibacterial agents |
| 09/28/2000 | WO2000022142A3 Cell signaling polypeptides and nucleic acids |
| 09/28/2000 | WO2000021515A3 Intranasal codeine for the rapid suppression of cough and rapid relief of pain |
| 09/28/2000 | WO2000020576A3 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein |
| 09/28/2000 | WO2000016808A3 Antibody directed enzyme prodrug therapy (edept) with glucoronidase |